Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
Commercialization of Selective Dyrk1a inhibitors for Down Syndrome
Sponsored by Iluminos Therapeutics, LLC
Active
$116.7K Funding
1 People
External
Related Topics
drug development,
down syndrome,
enzyme inhibitors,
commercialization,
therapeutic intervention
People
Christopher Hulme
Principal Investigator (PI)
Pharmacology and Toxicology
﹒Professor